| Literature DB >> 24619004 |
Seon-Koo Lee1, Ji Won Chun2, Jung Suk Lee3, Hae-Jeong Park4, Young-Chul Jung5, Jeong-Ho Seok5, Jae-Jin Kim6.
Abstract
Aberrant emotional salience attribution has been reported to be an important clinical feature in patients with schizophrenia. Real life stimuli that incorporate both positive and negative emotional traits lead to affective asymmetry such as negativity bias and positivity offset. In this study, we investigated the neural correlates of emotional salience attribution in patients with schizophrenia when affective asymmetry was processed. Fifteen patients with schizophrenia and 14 healthy controls were scanned using functional magnetic resonance imaging (fMRI) while performing an emotion judgment task in which two pictures were juxtaposed. The task consisted of responding to affective asymmetry condition (ambivalent and neutral) and affective symmetry conditions (positive and negative), and group comparisons were performed for each condition. Significantly higher activity in the medial prefrontal cortex and inferior frontal gyrus was observed for the ambivalent condition than for the other conditions in controls, but not in patients. Compared with controls, patients showed decreased activities in the dorsolateral prefrontal cortex, dorsal anterior cingulate cortex, insula, and putamen for the ambivalent condition, but no changes were observed for the neutral condition. Multiple prefrontal hypoactivities during salience attribution of negativity bias in schizophrenia may underlie deficits in the integrative processing of emotional information. Regional abnormalities in the salience network may be the basis of defective emotional salience attribution in schizophrenia, which is likely involved in symptom formation and social dysfunction.Entities:
Mesh:
Year: 2014 PMID: 24619004 PMCID: PMC3949688 DOI: 10.1371/journal.pone.0090792
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of patients with schizophrenia and healthy controls.
| Schizophrenia (N = 15) | Control (N = 14) | |||||
| 8 (53.3%) | 6 (42.9%) | X2/t | p | |||
| Male, n (%) | Mean | SD | Mean | SD | 0.318 | 0.573 |
| Age (years) | 31.7 | 6.8 | 30.6 | 5.5 | −0.471 | 0.64 |
| Education (years) | 13.7 | 1.7 | 16.1 | 2.4 | 3.228 | 0.003 |
| Duration of illness (years) | 10.3 | 6.9 | – | – | – | – |
| CP equivalent dose (mg) | 489.1 | 521.7 | – | – | – | – |
| SAS | 7.3 | 5.3 | 3.9 | 3.1 | −2.154 | 0.04 |
| Paranoia scale | 48.0 | 18.6 | 38.8 | 6.2 | −1.764 | 0.05 |
| PANSS_Total | 56.5 | 12.1 | – | – | – | – |
| PANSS_Positive | 13.4 | 4.2 | – | – | – | – |
| PANSS_Negative | 15.8 | 5.3 | – | – | – | – |
| PANSS_General | 27.3 | 7.5 | – | – | – | – |
SD, Standard deviation; CP, Chlorpromazine; SAS, Schizotypal Ambivalence Scale; PANSS, Positive and Negative Syndrome Scale.
*p<0.05,
**p<0.01.
Figure 1An example of the emotion judgment task.
Group comparison of the response rates in each condition.
| Condition | Response type | Response rate (%) | ||
| Schizophrenia (n = 15) | Control (n = 14) | p | ||
| Ambivalent | Missing | 5.0 (7.8) | 4.4 (5.4) | <0.0001 |
| Positive | 8.9 (12.3) | 10.9 (8.2) | 0.9828 | |
| Negative | 53.4 (31.2) | 53.6 (33.8) | 0.0435 | |
| nPnN | 32.7 (31.5) | 31.1 (31.8) | 0.6522 | |
| Positive | Missing | 2.6 (6.3) | 4.1 (5.2) | <0.0001 |
| Positive | 63.6 (26.3) | 86.8 (14.1) | <0.0001 | |
| Negative | 19.3 (22.5) | 2.0 (3.7) | <0.0001 | |
| nPnN | 14.5 (16.2) | 7.1 (9.9) | 0.0004 | |
| Negative | Missing | 1.8 (3.0) | 5.2 (6.7) | <0.0001 |
| Positive | 7.5 (15.0) | 2.1 (3.8) | <0.0001 | |
| Negative | 81.6 (26.3) | 91.4 (11.0) | <0.0001 | |
| nPnN | 9.1 (14.7) | 1.3 (2.4) | <0.0001 | |
| Neutral | Missing | 5.3 (9.5) | 5.0 (6.4) | <0.0001 |
| Positive | 23.6 (19.4)) | 5.9 (6.8) | <0.0001 | |
| Negative | 23.2 (26.8) | 2.3 (2.7) | <0.0001 | |
| nPnN | 47.9 (27.7) | 86.8 (8.7) | <0.0001 | |
Data are given as means and standard deviation (SD). Group effects were testified using the Generalized Linear Mixed Model (GLMM) with years of education as a covariate.
*indicates significant difference (p<0.01) after Bonferroni correction.
“nPnN” means neither positive nor negative. Missing represents that participants did not respond.
Figure 2Brain regions showing significant group×condition interaction and percent signal changes of the regions for each condition.
Error bar represents one standard error of the mean. * surpasses Holm-Bonferroni corrected threshold. AMB, ambivalent; POS, positive; NEG, negative; and NEU, neutral.
Decreased brain activities after small volume correction analysis in patients with schizophrenia compared with healthy controls.
| Brain region (Brodmann area) | Side | Voxel size | MNI Coordinates | Z-max | T | ||
| x | y | z | |||||
|
| |||||||
| DLPFC (46) | Left | 41 | −38 | 32 | 26 | 3.79 | 4.49 |
| Dorsal ACC (32) | Right | 45 | 10 | 28 | 26 | 4.16 | 5.10 |
| Insula (13) | Left | 20 | −44 | 16 | 2 | 4.53 | 5.77 |
| Putamen | Right | 18 | 18 | 6 | 2 | 3.50 | 4.05 |
| Left | 46 | −18 | 10 | 6 | 3.86 | 4.60 | |
|
| |||||||
| Insula (13) | Right | 25 | 40 | 20 | 0 | 3.85 | 4.58 |
|
| No voxel survive threshold | ||||||
|
| No voxel survive threshold | ||||||
The threshold was set at a family-wise error-corrected p<0.05. MNI, Montreal Neurological Institute; DLPFC, Dorsolateral prefrontal cortex; ACC, Anterior cingulate cortex.
Figure 3Brain regions showing decreased activities in patients compared with controls.
Positive findings were observed only in the ambivalent condition (A) and positive condition (B) L., left; R., right; DLPFC, dorsolateral prefrontal cortex; and ACC, anterior cingulate cortex.